GlaxoSmithKline Pharmaceuticals Limited — Others, 04-08-2025: Rumour Verification - Regulation 30(11)

GlaxoSmithKline Pharmaceuticals issued a clarification regarding a recent news report concerning potential US tariff and price cut pressures. The company stated that the news, which mentioned 'GSK', pertains to its ultimate parent company, GSK plc in the UK, and not GlaxoSmithKline Pharmaceuticals Limited itself. The Indian listed entity has no further information on this specific matter and does not expect any material impact on its own operations or share price from this development. This distinction is important for shareholders to note.